69 Health Tech Startups in Switzerland to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Advanced allosteric modulator therapeutics developer for neurological disorders. |
$63M · Series A | Xontogeny, Perceptive Advisors, Acorn Bioventures | 1 to 10 | Health Tech, Biotech | Geneva, Switzerland | •••••••••••@neurosterix.com | ||
Gene therapy platform. |
$6M · Seed | Life Extension Ventures, Zühlke Group, Oxford Seed Fund | 1 to 10 | Health Tech, Biotech | Geneva, Switzerland | •••••••••••@limula.ch | ||
Viral vector-based cancer vaccines developer. |
$82M · Series C | Bpifrance, 5AM Ventures, Abingworth | 1 to 10 | Health Tech, Biotech | B2C | Basel, Switzerland | •••••••••••@nouscom.com | |
Blood purification platform. |
$15M · Series B | Hemex, Belmondo, VP Venture Partners | 11 to 50 | Health Tech | B2B | Zürich, Switzerland | •••••••••••@hemotune.ch | |
Temperature controlled containers for the pharmaceutical industry. |
$116M · Series D | M&G Investments, MVM Life Science Partners, Tybourne Capital Management | 101 to 250 | Health Tech, Supply Chain & Logistics | B2B, SaaS | Zürich, Switzerland | •••••••••••@skycell.ch | |
Cardiac ablation system developer for treating cardiac arrhythmias. |
$58M · Series B | Earlybird Venture Capital, Gilde Healthcare, Advent Life Sciences | 1 to 10 | Health Tech | Lausanne, Switzerland | •••••••••••@argamedtech.com | ||
Antibody discovery and human immune repertoire analysis platform. |
$27M · Series C | Vesalius Biocapital Partners, Swisscanto Private Equity, Pureos Bioventures | 11 to 50 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@memo-therapeutics.com | |
Gene therapy research to tackle genetic diseases. |
$59M · Series A | Gimv | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@anjarium.com | |
Stair-climbing electric wheelchair manufacturer. |
$9M · Series A | RSBG Ventures | 51 to 100 | Health Tech, Manufacturing | B2C | Zürich, Switzerland | •••••••••••@scewo.com | |
Developer of small molecules to treat novel drug resistance pathways in cancer therapy. |
$20M · Series A | Altos Ventures, BioMedPartners, Redalpine | 1 to 10 | Health Tech, Biotech | Zürich, Switzerland | •••••••••••@tolremo.com | ||
Therapeutics developer for mast cell-mediated diseases. |
$3M · Seed | Forty51 Ventures | 1 to 10 | Health Tech, Biotech | Basel, Switzerland | •••••••••••@allegriatx.com | ||
Small molecule mitophagy inducers developer. |
$20M · Series A | ND Capital | 1 to 10 | Health Tech, Biotech | Lausanne, Switzerland | •••••••••••@vandria.com | ||
AI-powered hypertension management platform. |
$30M · Series A | Khosla Ventures, Molten Ventures, Translink Capital | 51 to 100 | Health Tech, AI | B2C, SaaS | Bern, Switzerland | •••••••••••@aktiia.com | |
Medical devices developer for spine specialist surgeons. |
$32M · Series B | Gimv, Ernst Gohner Stiftung | 101to 250 | Health Tech, Hardware | B2B | Geneva, Switzerland | •••••••••••@spineart.com | |
Non-invasive treatment for heart arrhythmias. |
$15M · Series A | EIC Accelerator, Panakes Partners | 1 to 10 | Health Tech, Biotech | B2B | Geneva, Switzerland | •••••••••••@eba-med.com | |
Self-adjuvanting and multi-antigen vaccine technology platform. |
$3M · Series A | AXA Investment Managers, Novo A/S, Adjuvant Capital | 11 to 50 | Health Tech, Biotech | Zürich, Switzerland | •••••••••••@lmtbio.com | ||
Glycanengineering platform. |
$49M · Series A | Sofinnova Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@glycoera.com | |
B2B SaaS human motion analysis platform. |
$30M | Creandum, Atomico, Eurazeo | 1 to 10 | Health Tech, AI, Machine Learning | B2B, SaaS | Zürich, Switzerland | •••••••••••@vay.ai | |
Neuro-interventional products developer for stroke and aneurysms. |
$6M · Series A | Nest Collective Foundation, Wyss Center, Verve Ventures | 1 to 10 | Health Tech, Manufacturing | B2C | Lausanne, Switzerland | •••••••••••@artiria-medical.com | |
Platform providing digital assessments and therapies for patient treatment and rehabilitation. |
$125M | Hambro Perks Ltd. | 101 to 250 | Health Tech, AR / VR, Biotech, Deep Tech, Business Intelligence | B2B | Lausanne, Switzerland | •••••••••••@mindmaze.com | |
RNA sequencing and transcriptomics analysis platform. |
$3M · Seed | Novalis Biotechnology Incubation, TechU Ventures, Foundation for Technological Innovation (FIT) | 1 to 10 | Health Tech, Biotech | B2B | Lausanne, Switzerland | •••••••••••@alitheagenomics.com | |
Healthcare procurement platform. |
$2M · Seed | Founderful | 11 to 50 | Health Tech, Supply Chain & Logistics | B2B, SaaS | Basel, Switzerland | •••••••••••@axmedrx.com | |
AI for early cancer detection. |
$25M · Series C | Xlife Sciences AG | 1 to 10 | Health Tech, AI | Zug, Switzerland | •••••••••••@4dlifetec.com | ||
Clinical-stage central nervous system (CNS) technology. |
$110M · Series B | Sofinnova Partners, Forbion Capital Partners, BioMedPartners | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@noemapharma.com | |
Intelligent healthcare warning systems. |
$10M · Series A | UBS, Zürcher Kantonal Bank | 1 to 10 | Health Tech, Business Intelligence | B2B | Bern, Switzerland | •••••••••••@qumea.com | |
Service platform that designs, constructs, and manages tech-enabled public toilet facilities. |
$5M | responsAbility | 1 to 10 | Health Tech, Proptech & Real Estate, Service Industry | B2B | Zürich, Switzerland | •••••••••••@misterloo.com | |
Home-test kit to perform blood tests. |
$10M · Series B | Speedinvest, Walter Ventures, Astor Perkins | 11 to 50 | Health Tech, Hardware, Manufacturing | B2C | Zürich, Switzerland | •••••••••••@bloomdiagnostics.com | |
Clinical-stage biotechnology developing treatments for cancer. |
$85M · Series B | EIC Accelerator, Syncona Partners LLP, M Ventures | 11 to 50 | Health Tech, Biotech | Geneva, Switzerland | •••••••••••@ionctura.com | ||
Manufacturer of drugs to combat the effects of ageing. |
$10M · Series A | Prima Materia | 11 to 50 | Health Tech, Biotech | B2C | Lausanne, Switzerland | •••••••••••@epiterna.com | |
Accurate monitoring and treatment platform for sleep bruxism and sleep apnea. |
$3M · Seed | Zürcher Kantonal Bank, Supermoon Capital, Creadd Ventures | 1 to 10 | Health Tech, Biotech | Lausanne, Switzerland | •••••••••••@aesyra.com | ||
Next-generation laboratory equipment developers. |
$13M · Series A | imec.xpand, Swisscanto Private Equity | 1 to 10 | Health Tech, Hardware | Lausanne, Switzerland | •••••••••••@nagibio.ch | ||
Clinical biotech firm focused on revolutionizing cell invasion research. |
$4M · Seed | High-Tech Gründerfonds, Verve Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Zürich, Switzerland | •••••••••••@invasight.com | |
Software platform to identify and analyze key opinion leaders in specific therapeutic areas. |
$12M | AlbionVC, Octopus Ventures | 11 to 50 | Health Tech, Media and Entertainement, Business Intelligence | B2B, Marketplace | Zug, Switzerland | •••••••••••@peakdata.com | |
Medtech solutions for achieving more effective outcomes in spinal surgery. |
$10M | Swisscom Ventures | 11 to 50 | Health Tech, Hardware, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@neo-medical.com | |
Developer of oral therapeutics to treat complex autoimmune diseases. |
$3M · Seed | Forty51 Ventures | 1 to 10 | Health Tech, Pharma | Basel, Switzerland | •••••••••••@mystheratx.com | ||
Platform engineering next-generation T cell receptor therapies. |
$15M · Seed | Novo A/S, Pureos Bioventures | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Basel, Switzerland | •••••••••••@engimmune.com | |
Platform for observing live cells in 3D without damaging them. |
$20M | Swisscom Ventures | 1 to 10 | Health Tech, Biotech, Pharma, Manufacturing, Business Intelligence | B2B, SaaS | Lausanne, Switzerland | •••••••••••@nanolive.ch | |
Program to increase human lifespan. |
$5M · Seed | Maximon | 11 to 50 | Health Tech, Biotech | B2C | Zug, Switzerland | •••••••••••@biolytica.com | |
Longevity health products maker. |
$9M · Series C | L'Oreal, Nestlé Health Science, Business Opportunities for L'Oréal Development | 11 to 50 | Health Tech, Manufacturing | B2C | Lausanne, Switzerland | •••••••••••@timelinenutrition.com | |
Clinically tested, patent-protected dietary therapy for migraines. |
$4M · Seed | R42 Group, Healthspan Capital | 1 to 10 | Health Tech, Foodtech | B2C | Basel, Switzerland | •••••••••••@keto.swiss | |
Platform providing evidence-based digital mental wellbeing and health solutions in Switzerland. |
$1M · Pre Seed | Wingman Ventures | 11 to 50 | Health Tech, Business Intelligence | B2B, SaaS | Zürich, Switzerland | •••••••••••@kyanhealth.com | |
Textile technology focused on health monitoring. |
$1M | Verve Ventures, Capnamic Ventures | 11 to 50 | Health Tech, Hardware, Fashion, Manufacturing, Business Intelligence, Wearables | B2B, SaaS | Zürich, Switzerland | •••••••••••@nanoleq.com | |
Immunotherapy platform for cancer. |
$330k · Pre Seed | Lightspeed Venture Partners, Gimv, BioMedPartners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@immunostherapeutics.com | |
AI-based tool that assesses patients' risk of cognitive impairment after surgery. |
$1M · Pre Seed | Plug and Play Spain, Forward VC | 1 to 10 | Health Tech, Hardware | B2B, SaaS | Zürich, Switzerland | •••••••••••@pipra.ch | |
Platform offering tools to enhance the development of personalized and precision medicine. |
$20M | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Zürich, Switzerland | •••••••••••@bcplatforms.com | ||
Startup based in Zürich focused on enabling the medical community to provide healthcare at home. |
$929k · Seed | Verve Ventures | 11 to 50 | Health Tech | B2B, SaaS | Zürich, Switzerland | •••••••••••@sleepiz.com | |
Fertility-tracking bracelet maker. |
$110k · Pre Seed | Khosla Ventures, Zürcher Kantonal Bank, Swisscom Ventures | 51 to 100 | Health Tech, Femtech | B2C | Zürich, Switzerland | •••••••••••@avawomen.com | |
Developer of fibrotic encapsulation solutions in implantable medical devices. |
$110k · Pre Seed | Verve Ventures, StartAngels Network, Venture Kick | 1 to 10 | Health Tech, Hardware | Zürich, Switzerland | •••••••••••@hylomorph-medical.com | ||
Light wearable support system developer. |
$102k · Pre Seed | Venture Kick | 251 to 500 | Health Tech, Hardware | B2B | Zürich, Switzerland | •••••••••••@auxivo.com | |
Biotechnology platform developing therapies by investing in people and ideas. |
$25M · Series A | 1 to 10 | Health Tech, Fintech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@rejuveron.com | ||
Platform creating soft implantable electrodes for nervous system interfaces. |
$169k · Pre Seed | Venture Kick | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Manufacturing | B2B | Geneva, Switzerland | •••••••••••@neurosoft-bio.com | |
Developer of an antibody-drug conjugates (ADCs). |
$110k · Pre Seed | btov Partners, Pureos Bioventures, Redalpine | 1 to 10 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@ararisbiotech.com | |
Clinical stage developer focused on providing an oral treatment for patients using a bradykinin B2 receptor antagonist. |
$80M · Series C | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Zug, Switzerland | •••••••••••@pharvaris.com | ||
Medical device developer focused on tools for minimally invasive surgeries. |
$90M · Series E | 1 to 10 | Health Tech, Deep Tech, Robotics, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@distalmotion.com | ||
Clinical-stage biopharmaceutical company developing drugs for rare diseases. |
$16M · Series A | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Geneva, Switzerland | •••••••••••@chordtherapeutics.com | ||
Connect travellers with fitness and wellness activities. |
$2M · Seed | 11 to 50 | Health Tech, Travel Tech | B2C, Marketplace | Zürich, Switzerland | •••••••••••@boddy.travel | ||
Quantum sensing technology for nanoscale imaging. |
$2M · Seed | Quantonation, High-Tech Gründerfonds, Verve Ventures | 11 to 50 | Health Tech, Hardware, Biotech, Navigation and Mapping, Manufacturing | B2B | Basel, Switzerland | •••••••••••@qnami.ch | |
Platform that identifies the ideal treatment for each cancer patient’s disease. |
$7M | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Pharma | Zürich, Switzerland | •••••••••••@navignostics.com | |||
Automated visual inspection for pharma. |
$877k · Seed | Spicehaus Partners | 1 to 10 | Health Tech | Basel, Switzerland | •••••••••••@axom.tech | ||
Planted is a food processing company that specializes in plant-based meals. |
$18M · Series A | 51 to 100 | Health Tech, Foodtech | Zürich, Switzerland | •••••••••••@eatplanted.com | |||
True precision medicine through single-cell science |
$1M · Series A | Verve Ventures, Swisscom Ventures | 11 to 50 | Health Tech, AI, Biotech | B2B | Basel, Switzerland | •••••••••••@scailyte.com | |
AI-powered navigation device maker for blind and visually impaired people. |
$1M · Seed | Serpentine Ventures | 1 to 10 | Health Tech, Navigation and Mapping | B2C | Lausanne, Switzerland | •••••••••••@biped.ai | |
Biotechnology company creating vaccines and immunotherapies. |
$8M · Series B | 11 to 50 | Health Tech, Biotech | B2B | Zürich, Switzerland | •••••••••••@virometix.com | ||
Near-eye light-field display technology providing true optical depth and better immersion for virtual and mixed reality experiences. |
$4M | Verve Ventures, Swisscom Ventures, DAA Capital Partners | 11 to 50 | Health Tech, AR / VR, Manufacturing | B2B, SaaS | Lausanne, Switzerland | •••••••••••@creal.com | |
Pathogen detection technology that provides accurate results in under 2 hours. |
$6M · Series B | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence | B2B | Zürich, Switzerland | •••••••••••@rqmicro.com | ||
Health tracking for preventive medicine. |
$6M · Seed | 11 to 50 | Health Tech | B2C | Zürich, Switzerland | •••••••••••@care.me | ||
Personal care products manufacturing company. |
$4M · Seed | 11 to 50 | Health Tech, Manufacturing | B2C | Zürich, Switzerland | •••••••••••@alpinewhite.com | ||
Platform for developing curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders. |
$50M · Series A | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Basel, Switzerland | •••••••••••@cimeio.com | ||
Gene precision delivery platform that enhances the safety, effectiveness, and accuracy of biologic therapies. |
$30M · Series A | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Basel, Switzerland | •••••••••••@vectorbiopharma.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.